Juhan-Vague, I <br/><br/>
The plasminogen activator inhibitor-1 -675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH study.  [electronic resource] 

 -  Journal of thrombosis and haemostasis : JTH  Nov 2003 
 - 2322-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-7933 
<br/><br/><label>Standard No.: </label>10.1046/j.1538-7836.2003.00458.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Case-Control Studies<br/>Europe--epidemiology<br/>Genotype<br/>Hemostasis<br/>Humans<br/>Insulin--blood<br/>Insulin Resistance<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--blood<br/>Plasminogen Activator Inhibitor 1--genetics<br/>Polymorphism, Genetic<br/>Proinsulin--blood<br/>Risk Factors